|
2021 Journal Article Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: Protocol for a phase 2, randomised, double-blind, placebo-controlled trialVivash, Lucy, Bertram, Kelly L, Malpas, Charles B, Marotta, Cassandra, Harding, Ian H, Kolbe, Scott, Fielding, Joanne, Clough, Meaghan, Lewis, Simon J G, Tisch, Stephen, Evans, Andrew H, O'Sullivan, John D, Kimber, Thomas, Darby, David, Churilov, Leonid, Law, Meng, Hovens, Christopher M, Velakoulis, Dennis and O'Brien, Terence J (2021). Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: Protocol for a phase 2, randomised, double-blind, placebo-controlled trial. BMJ Open, 11 (12) e055019, e055019. doi: 10.1136/bmjopen-2021-055019 |
|
2021 Conference Publication Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s DiseaseNikles, J., Mitchell, G. K., Smith, S. S., McGree, J. M., McDonald, S., Poli, N., Senior, H., Tan, S., Dissanyaka, N., Ritchie, A. and O'Sullivan, J. D. (2021). Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s Disease. Australian Clinical Trials Alliance conference, Sydney, NSW, Australia, November 2021. |
|
2021 Journal Article Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementiaDissanayaka, Nadeeka N., Forbes, Elana J., Yang, Ji Hyun J., Pourzinal, Dana, O’Sullivan, John D., Mitchell, Leander K., Copland, David A., McMahon, Katie L. and Byrne, Gerard J. (2021). Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia. Journal of Neurology, 269 (3), 1600-1609. doi: 10.1007/s00415-021-10736-x |
|
2021 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J., Adam, R., Copland, D., Yang, J.H.J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2021). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocol. Australia Dementia Forum 2021, Online, 31 May - 1 June 2021. |
|
2021 Journal Article Defining atypical anxiety in Parkinson's diseaseForbes, Elana J., Byrne, Gerard J., O'Sullivan, John D., Yang, Jihyun, Marsh, Rodney and Dissanayaka, Nadeeka N. (2021). Defining atypical anxiety in Parkinson's disease. Movement Disorders Clinical Practice, 8 (4), 571-581. doi: 10.1002/mdc3.13193 |
|
2021 Journal Article Neural correlates of attentional deficits in Parkinson’s disease patients with mild cognitive impairmentYang, Jihyun, Pourzinal, Dana, McMahon, Katie L., Byrne, Gerard J., Copland, David A., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2021). Neural correlates of attentional deficits in Parkinson’s disease patients with mild cognitive impairment. Parkinsonism and Related Disorders, 85, 17-22. doi: 10.1016/j.parkreldis.2021.02.009 |
|
2021 Conference Publication Investigating resting state functional connectivity in sub-phenotypes of mild cognitive impairment in Parkinson’s diseasePourzinal, D., Yang, J.H., Byrne, G.J., O’Sullivan, J.D., McMahon, K., Copland, D.A. and Dissanayaka, N. (2021). Investigating resting state functional connectivity in sub-phenotypes of mild cognitive impairment in Parkinson’s disease. Australia Dementia Forum 2021, Online, 31 May – 1 June 2021. |
|
2021 Journal Article Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE studyEvans, Andrew, Fung, Victor S. C., O'Sullivan, John D., Stell, Rick, White, Richard, Williams, David R., Femia, Samira and Onuk, Koray (2021). Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study. Clinical Parkinsonism and Related Disorders, 4 100075, 100075. doi: 10.1016/j.prdoa.2020.100075 |
|
2020 Conference Publication Identification and clinical characteristics of mild cognitive impairment in Parkinson's diseaseYang, J., Forbes, E., Pourzinal, D., McMahon, K., Copland, D., Byrne, G., O'Sullivan, J., Mitchell, L. and Dissanayaka, N. (2020). Identification and clinical characteristics of mild cognitive impairment in Parkinson's disease. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementiaForbes, E., Byrne, G. J., Yang, J. H. J., O'Sullivan, J., Copland, D. A., McMahon, K. L., Mitchell, L. K. and Dissanayaka, N. N. (2020). Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Neural correlates of semantic fluency deficits in Parkinson’s disease patients with mild cognitive impairmentYang, J., Copland, D., McMahon, K., Byrne, G., O'Sullivan, J. and Dissanayaka, N. (2020). Neural correlates of semantic fluency deficits in Parkinson’s disease patients with mild cognitive impairment. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2020). Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocol. UQ Faculty of Medicine Higher Degree by Research Student Symposium, Brisbane, QLD Australia, 23-27 November 2020. |
|
2020 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, G. and Dissanayaka, N. (2020). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocol. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020. |
|
2020 Conference Publication Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s diseasePourzinal, D., Yang, J. H., Byrne, G. J., O'Sullivan, J. D., Mitchell, L. K., McMahon, K. L., Copland, D. A. and Dissanayaka, N. N. W. (2020). Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s disease. Australian Society for Medical Research Queensland Postgraduate Student Conference, Online, 11 November 2020. |
|
2020 Conference Publication Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study updateDissanayaka, N., Byrne, G. J., Mitchell, L. K., O'Sullivan, J. D., Padmassini, A., White, E. X., Yang, J. H. J., Forbes, E., Thangavelu, K., Au, T., Lehn, A., Adam, R. and Pachana, N. A. (2020). Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study update. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020. |
|
2020 Conference Publication Defining atypical anxiety in Parkinson’s diseaseForbes, E., Byrne, G. J., Yang, J. H. J., O'Sullivan, J., Copland, D. A., McMahon, K. L., Mitchell, L. K. and Dissanayaka, N. N. (2020). Defining atypical anxiety in Parkinson’s disease. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Profiling atypical anxiety in Parkinson’s DiseaseForbes, E., Byrne, G.J., Yang, J.H.J., O'Sullivan, J., Copland, D.A., McMahon, K.L., Mitchell, L.K. and Dissanayaka, N.N. (2020). Profiling atypical anxiety in Parkinson’s Disease. MDS Virtual Congress 2020, Online, 12-16 September 2020. |
|
2020 Journal Article Differential patterns of internally generated responses in parkinsonian disordersTjokrowijoto, Priscilla, Ceslis, Amelia, O'Sullivan, John D., Adam, Robert, Mellick, George, Silburn, Peter and Robinson, Gail A. (2020). Differential patterns of internally generated responses in parkinsonian disorders. Neuropsychologia, 146 107569, 107569. doi: 10.1016/j.neuropsychologia.2020.107569 |
|
2020 Journal Article Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysisPourzinal, Dana, Yang, Ji Hyun J., Byrne, Gerard J., O’Sullivan, John D., Mitchell, Leander, McMahon, Katie L., Copland, David A. and Dissanayaka, Nadeeka N. (2020). Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis. Journal of Neurology, 267 (11), 3213-3222. doi: 10.1007/s00415-020-09977-z |
|
2020 Journal Article Too much of a good thing: hedonistic homoeostatic dysregulation and other behavioural consequences of excessive dopamine replacement therapy in Parkinson’s diseaseO'Sullivan, John D (2020). Too much of a good thing: hedonistic homoeostatic dysregulation and other behavioural consequences of excessive dopamine replacement therapy in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 91 (6), 566-567. doi: 10.1136/jnnp-2019-322378 |
